As the inaugural Executive Fellow in Health Care Association Leadership, Drake Reiter, PharmD, RPh, recounts his experience working at AMCP. From leading the development of the AMCP Digital Therapeutics Group to participating in board of directors meetings, learn more about his experience.
AMCP responded in a letter to the editor of Health Affairs stressing that managed care tools work to address the misalignment between drug prices and clinical value. In her latest blog post, AMCP CEO Susan Cantrell dives deeper into the reason behind the response and how it supported the need for value-based pricing.
Nearly 40 experts representing payers, pharmacy benefit managers, integrated delivery systems, patient advocates, academicians, and other key stakeholders in the managed care setting convened for AMCP’s Partnership Forum Addressing Evidence Gaps in the Expedited Review Process: Payer Perspectives.
AMCP signed onto an amicus brief in support of the OSHA Rule on COVID-19 Vaccination and Testing case in the U.S. Court of Appeals for the Sixth Circuit.
AMCP joined other organizations to call on the business community to support the new federal requirement that those working for companies with more than 100 employees be vaccinated for COVID.
On Nov. 2, AMCP joined a pharmacy stakeholder coalition letter to CMS requesting the agency use its PREP Act authority to establish payment mechanisms for Medicare and Medicaid to reimburse pharmacists for COVID-19 patient assessment services.